Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Playford

Showing results (21-30 of 99) with videos related to

Pageof 10
Sort By:
Open Heart|April 2, 2025
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunctionSeshika Ratwatte, Simon Stewart, David Playford, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 14, 2022
Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of AustraliaSophie Offen, David Playford, Geoff Strange, et al.
Journal of Diabetes and Its Complications|November 4, 2020
Relative incidence and predictors of pulmonary arterial hypertension complicating type 2 diabetes: The Fremantle Diabetes Study Phase INishant Nundlall, David Playford, Timothy M E Davis, et al.
International Journal of Cardiology|November 8, 2022
Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of AustraliaSophie Offen, Geoff Strange, David Playford, et al.
Open Heart|December 3, 2024
Prevalence and prognostic significance of pulmonary hypertension in adults with left ventricular diastolic dysfunctionSeshika Ratwatte, David Playford, Geoff Strange, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 3, 2021
Markers of Elevated Left Ventricular Filling Pressure Are Associated with Increased Mortality in Nonsevere Aortic StenosisLauren C Giudicatti, Sally Burrows, David Playford, et al.
Open Heart|June 6, 2023
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomesSeshika Ratwatte, Geoff Strange, David Playford, et al.
Internal Medicine Journal|June 28, 2022
Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomesPyi Naing, Nadarajah Kangaharan, Gregory M Scalia, et al.
Heart, Lung & Circulation|December 13, 2016
Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future DirectionPyi Naing, Harveen Kuppusamy, Gregory Scalia, et al.
Heart (British Cardiac Society)|April 3, 2023
Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomesSeshika Ratwatte, Simon Stewart, Geoff Strange, et al.
Pageof 10

Showing results (21-30 of 99) with videos related to

Sort By:
Pageof 10
Open Heart|April 2, 2025
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunctionSeshika Ratwatte, Simon Stewart, David Playford, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|April 14, 2022
Adverse Prognostic Impact of Even Mild or Moderate Tricuspid Regurgitation: Insights from the National Echocardiography Database of AustraliaSophie Offen, David Playford, Geoff Strange, et al.
Journal of Diabetes and Its Complications|November 4, 2020
Relative incidence and predictors of pulmonary arterial hypertension complicating type 2 diabetes: The Fremantle Diabetes Study Phase INishant Nundlall, David Playford, Timothy M E Davis, et al.
International Journal of Cardiology|November 8, 2022
Prevalence and prognostic impact of tricuspid regurgitation in patients with cardiac implantable electronic devices: From the national echocardiography database of AustraliaSophie Offen, Geoff Strange, David Playford, et al.
Open Heart|December 3, 2024
Prevalence and prognostic significance of pulmonary hypertension in adults with left ventricular diastolic dysfunctionSeshika Ratwatte, David Playford, Geoff Strange, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 3, 2021
Markers of Elevated Left Ventricular Filling Pressure Are Associated with Increased Mortality in Nonsevere Aortic StenosisLauren C Giudicatti, Sally Burrows, David Playford, et al.
Open Heart|June 6, 2023
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomesSeshika Ratwatte, Geoff Strange, David Playford, et al.
Internal Medicine Journal|June 28, 2022
Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomesPyi Naing, Nadarajah Kangaharan, Gregory M Scalia, et al.
Heart, Lung & Circulation|December 13, 2016
Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future DirectionPyi Naing, Harveen Kuppusamy, Gregory Scalia, et al.
Heart (British Cardiac Society)|April 3, 2023
Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomesSeshika Ratwatte, Simon Stewart, Geoff Strange, et al.
Pageof 10